Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single Cell RNA Sequencing of Metastatic Adrenocortical Carcinoma and Tumor-Free Tissue.

ABSTRACT: Single Cell RNA Sequencing of Metastatic Adrenocortical Carcinoma and Tumor-Free Tissue.

PROVIDER: PRJNA1241337 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Single Cell RNA Sequencing of Metastatic Adrenocortical Carcinoma and Tumor-Free Tissue.

Project description:Single Cell RNA Sequencing of Metastatic Adrenocortical Carcinoma and Tumor-Free Tissue.

| PRJNA1241336 | ENA

Expression data from human metastatic adrenocortical carcinoma

Project description:CXCR4 expression by metastatic adrenocortical carcinoma is heterogeneous among patients and among lesions We used microarrays for 57 ACC metastases from 42 patients to evaluate gene expression in different lesions from same patients and over time, focusing on CXCR4 expression and other genes correlating with CXCR4 expression

2017-11-24 | GSE90713 | GEO

Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors

Project description:Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors

| PRJNA484071 | ENA

Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors

Project description:Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors

| PRJNA484072 | ENA

Identification of new TCF21 targets in adrenocortical carcinoma cells

Project description:Transcription factor 21 (TCF21) directly binds and regulates SF1 in tumor and normal adrenocortical cells, and both are involved in the development and steroidogenesis of the adrenal cortex. TCF21 is a tumor suppressor gene and its expression is reduced in malignant tumors. In adrenocortical tumors, it is less expressed in adrenocortical carcinomas (ACC) than in adrenocortical adenomas (ACA) and normal tissue. However, a comprehensive analysis to identify TCF21 targets have not yet been conducted in any type of cancer. In this study, we performed Chromatin Immunoprecipitation and Sequencing (ChIP-Seq) in adrenocortical carcinoma cell line (NCI-H295R) overexpressing TCF21, with the aim of identifying TCF21 new targets. The five most frequently identified sequences corresponded to the PRDM7, CNTNAP2, CACNA1B, PTPRN2 and KCNE1B genes. Validation experiments showed that, in NCI-H295R cells, TCF21 regulates gene expression positively in PRDM7 and negatively in CACNA1B. Recently, it was observed that the N-type calcium channel v2.2 (Cav2.2) encoded by CACNA1B gene is important in Angiotensin II signal transduction for corticosteroid biosynthesis in NCI-H295R adrenocortical carcinoma cells. Indeed, TCF21 inhibits CACNA1B and Cav2.2 expression in NCI-H295R. In addition, in a cohort of 55 adult patients with adrenocortical tumor, CACNA1B expression was higher in ACC than ACA, and was related to poor disease-free survival in ACC patients. These results suggest a mechanism of steroidogenesis control by TCF21 in adrenocortical tumor cells, in addition to the control observed through SF1 inhibition. Importantly, steroid production could impair tumor immunogenicity, contributing to the immune resistance described in adrenal cancer.

2022-06-30 | GSE179308 | GEO

Adrenocortical Carcinoma Gene Expression Profiling

Project description:Adrenocortical Carcinoma Gene Expression Profiling

| PRJNA121859 | ENA

Tumor Heterogeneity in Metastatic Adrenocortical Tumors

Project description:<p>We have analyzed 33 human metastatic adrenocortical tumors from 14 patients with advanced metastases and performed whole exome sequencing to identify novel signatures in these tumors. We observed tumor heterogeneity in these tumors coming from the same metastatic tissue site across different patients while the different metastatic tumor sites coming from the same patient are more homogenous in nature.</p>

| phs001658 | dbGaP

microRNA expression analysis of metastatic adrenocortical tumors

Project description:microRNA expression analysis of metastatic adrenocortical tumors

| PRJNA600261 | ENA

Gene expression analysis of metastatic adrenocortical tumors

Project description:Gene expression analysis of metastatic adrenocortical tumors

| PRJNA600262 | ENA

Exression profiling of 9-cisRA in adrenocortical carcinoma cell line

Project description:Adrenocortical carcinoma is a rare tumour with a poor prognosis. The currently available medical treatment options of adrenocortical cancer are limited. In the present study we examine the potential antitumoral effects of 9-cis-retinoic acid (9-cisRA) on the adrenocortical cancer cell line NCI-H295R.

2013-02-10 | GSE43090 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data